Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Soluble suppression of tumorigenicity 2 (sST2) receptor is a biomarker that is elevated in certain systemic inflammatory diseases. Comorbidity‐driven microvascular inflammation is postulated to play a key role in heart failure with preserved ejection fraction (HFpEF) pathophysiology, but...

Descripción completa

Detalles Bibliográficos
Autores principales: AbouEzzeddine, Omar F., McKie, Paul M., Dunlay, Shannon M., Stevens, Susanna R., Felker, G. Michael, Borlaug, Barry A., Chen, Horng H., Tracy, Russell P., Braunwald, Eugene, Redfield, Margaret M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523750/
https://www.ncbi.nlm.nih.gov/pubmed/28214792
http://dx.doi.org/10.1161/JAHA.116.004382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523750/
https://www.ncbi.nlm.nih.gov/pubmed/28214792
http://dx.doi.org/10.1161/JAHA.116.004382

Ejemplares similares